Inqaba Biotec West Africa (IBWA) is a subsidiary of Inqaba Biotechnical Industries (Pty) Ltd, South Africa. The company was incorporated in 2014 and located opposite IITA in Ibadan, Nigeria. Currently, IBWA also operates in Ghana, Senegal, Cameroon, Benin Republic, and Mali, having established itself as a leader in delivering high-quality laboratory products, equipment, and services. Our core services include, oligonucleotide synthesis, Sanger DNA sequencing, Next Generation Sequencing, bioinformatics, molecular diagnostics, fragment analysis, as well as workshops and instrument maintenance.

Technically orientated scientist with interpersonal aptitude and extensive experience in Molecular Diagnostics. Sales success has always been based on sincere product expertise and open client communication. Using the philosophy of integrity in sales increased the Molecular Diagnostic portfolio to be the single largest revenue generating entity within Inqaba Biotec. Created the local subsidiary of Seegene to create a more direct, technical based link with the Sub-Saharan territories.

Mr Victor holds a Bachelor’s degree in Medical Laboratory Science with Medical Microbiology specialty, Master in Disaster Risk Management and Development Study and currently enrolled in M.Phil./Ph.D. Public Health program in Nasarawa State University, Keffi.

Dr. Coker holds a PhD in Epidemiology from the University of Maryland School of Medicine (2015), a Master of Public Health from Johns Hopkins Bloomberg School of Public Health (2007), and a Bachelor of Dental Surgery from the University of Ibadan, Nigeria (2004). Her research focuses on characterizing the effect of early-life infections (including HIV/AIDS), behavioural and environmental factors on microbial composition in the context of oral/dental disease.